Evaluation of Diaphragm in Chronic Obstructive Pulmonary Disease Patients by Ultrasound in Relation to Severity
1 other identifier
observational
80
1 country
1
Brief Summary
The study of the diaphragm is an important point in the assessment of COPD patients. Ultrasonographic evaluation of the diaphragm is considered a simple, non-invasive, available bedside technique. Ultrasonography can be used for evaluation of the site, structure, and motion of the diaphragm, assessment of excursion, and thickness. The aim of the study is ultrasonographic assessment of the diaphragm in COPD patients and its relation to disease severity
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 14, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 14, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 14, 2020
CompletedFirst Submitted
Initial submission to the registry
September 3, 2021
CompletedFirst Posted
Study publicly available on registry
September 5, 2021
CompletedSeptember 30, 2021
September 1, 2021
6 months
September 3, 2021
September 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
measure diaphragmatic thickness by ultrasound
measure diaphragmatic thickness at total lung capacity and residual volume in millimetres to calculate diaphragm thickness fraction
1 year study
measure diaphragm excursion by ultrasound
measure diaphragm excursion in centimetres at zone of apposition
1 year study
Secondary Outcomes (2)
spirometry assessment
1 year study
questionnaires
1 year study
Study Arms (2)
40 COPD patients
all participants were subjected to : history - clinical examination - spirometry - ultrasound evaluation of diaphragmatic function
40 healthy individuals
all participants were subjected to : history - clinical examination - spirometry - ultrasound evaluation of diaphragmatic function
Interventions
ultrasound assessment of diaphragm function
Eligibility Criteria
40 COPD patients and 40 age matched healthy control
You may qualify if:
- Stable COPD patients aged more than 40 years who were diagnosed and classified into four groups of severity according to GOLD 2020.
- Age and sex-matched healthy controls
You may not qualify if:
- Patient with a known neuromuscular disorder.
- Patient with known anatomical malformation of the diaphragm.
- Post abdominal or thoracic surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fayoum University Hospital
Al Fayyum, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Enas S Farhat, MD
Fayoum University Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- fayoum university hospital
Study Record Dates
First Submitted
September 3, 2021
First Posted
September 5, 2021
Study Start
December 14, 2019
Primary Completion
June 14, 2020
Study Completion
December 14, 2020
Last Updated
September 30, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share
after the submission is finished, the individual participant data will be shared to other researchers